2017
DOI: 10.1016/j.cellimm.2017.04.002
|View full text |Cite
|
Sign up to set email alerts
|

Association between cigarette smoking and impaired clinical symptoms in systemic sclerosis: A review

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
5
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 16 publications
(5 citation statements)
references
References 59 publications
0
5
0
Order By: Relevance
“…Smoking can act as an exacerbating factor, where it increases morbidity and mortality of SSc patients by worsening digital ulcers, 80 gastrointestinal symptoms, 81 pulmonary function, and increasing the likelihood of lung cancer, 82 but evidence of smoking as a disease trigger is limited. 83 De Decker et al observed a higher proportion of smokers among SSc patients exposed to silica and/or solvents, indicating that smoking might be a confounding factor or might provide a synergistic effect when combined with other toxins.…”
Section: Smokingmentioning
confidence: 99%
See 1 more Smart Citation
“…Smoking can act as an exacerbating factor, where it increases morbidity and mortality of SSc patients by worsening digital ulcers, 80 gastrointestinal symptoms, 81 pulmonary function, and increasing the likelihood of lung cancer, 82 but evidence of smoking as a disease trigger is limited. 83 De Decker et al observed a higher proportion of smokers among SSc patients exposed to silica and/or solvents, indicating that smoking might be a confounding factor or might provide a synergistic effect when combined with other toxins.…”
Section: Smokingmentioning
confidence: 99%
“…28 More studies accounting for confounding factors such as educational level, socioeconomic status, and alcohol consumption are needed. 82…”
Section: Exposures With Probable Association (Level III Evidence)mentioning
confidence: 99%
“…Hypoxia and oxidative stress have been implicated in the pathophysiology of its generalized microangiopathy and fibrosis . Although smoking does not appear to confer a risk for SSc development , it has vasoconstrictive effects and increases free‐radical exposure, and together with other proinflammatory and immunomodulatory effects may exacerbate SSc manifestations . Data on the role of tobacco exposure with regard to the severity of SSc organ manifestations and progression are, however, scarce, and at times contradictory .…”
mentioning
confidence: 99%
“…First, the NHIRD does not include personal information regarding lifestyles, body mass index values, smoking, and alcohol use. Smoking currently is still not clarified as a certain risk factor of SSc [ 38 ]. In order to minimize these biases, we had adjusted COPD and comorbidities to proxy these lifestyle-related diseases.…”
Section: Discussionmentioning
confidence: 99%